VIRGINIA CITY, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE American: LODE, the “Company”) today announced that one of its strategic investees, Bioleum Corporation (“Bioleum”), acquired substantially all of the patents and other intellectual property assets of RenFuel K2B AB (“RenFuel”) through a wholly-owned subsidiary of Bioleum, including RenFuel’s patented catalytic esterification process to refine Bioleum’s proprietary biointermediates. The purchase price includes an $18.1 million closing payment comprised of $12.5 million paid with 520,833 shares of Bioleum common stock, $2.5 million paid in the form of warrants to purchase an additional 104,167 shares of Bioleum common stock at an exercise price of $24 per share, $2.6 million in debt forgiveness, and cash of $500,000. The purchase price further includes a contingent...

EL MONTE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that it has entered into a definitive Share Purchase Agreement to acquire 100% of the outstanding equity of New Classic Home Furnishings, Inc. The terms of the agreement remain unchanged from those previously disclosed on October 24, with a total consideration of $18 million on a debt-free basis, including a post-close earn-out. The transaction will be funded from GigaCloud’s existing cash on hand. The Board of Directors of GigaCloud has unanimously approved the transaction. The transaction is expected to close on January 2, 2026, subject to satisfaction of customary closing conditions. About GigaCloud Technology...

In forming a new entity in Texas, the goal of this initiative is to attract additional groups and individual physicians to join together in the ownership and leadership of a private practice group that yields the benefits of scale and independence. Tarrytown, New York, Dec. 03, 2025 (GLOBE NEWSWIRE) — ENT & Allergy Associates (ENTA), in collaboration with its management services organization, Hümi (formerly known as Quality Medical Management Services USA, LLC), is making a major strategic expansion with the formation of ENT & Allergy Associates of Texas, PLLC (ENTA–TX) through a partnership with Houston ENT & Allergy, effective January 1, 2026. This marks ENTA’s first presence in Texas and extends its physician owned, patient-centered specialty care network beyond New York, New Jersey, and Pennsylvania.  In forming...

Enhancing Power Management Aftermarket Service Portfolio With Reverse Engineering Capabilities, Renewable Expertise & MoreENA Electronics Inc. Endorsed LogoMoving forward, ENA will use an endorsed logo, which will include the phrase, “AN IPS COMPANY.”ENA HeadquartersENA headquarters are located at 80 Bancroft St, Hamilton, ON L8E 2W5, Canada. In addition, the company has two additional warehouse locations: 190 Brockley Drive, Unit 2, Hamilton, Ontario, L8E 3C5, Canada, which is also the company’s primary shipping and receiving address, and a second warehouse in the United States: c/o Fyke Trading (USA) Inc., 2221 Kenmore Avenue, Suite 106, Buffalo NY USA 14207-1360.Greenville, SC, Dec. 03, 2025 (GLOBE NEWSWIRE) — Integrated Power Services (IPS), a world-class provider of electrical, mechanical,...

Founder Tristan Schukraft continues his mission to preserve iconic queer destinations while evolving them for a new era of gay luxury and hospitalityPool Party at The Crown & AnchorLocated in the heart of Provincetown’s historic center, The Crown & Anchor features six bars, a restaurant, a 17-room hotel, and multiple nightlife and performance venues, including The Paramount, The Crown Cabaret, and The Vault.The Crown & Anchor on Commercial Street in ProvincetownTristan Schukraft’s Tryst Hospitality announced its acquisition of The Crown & Anchor, Provincetown’s legendary hotel, restaurant, and entertainment complex on Commercial StreetProvincetown, MA, Dec. 03, 2025 (GLOBE NEWSWIRE) — Tristan Schukraft’s Tryst Hospitality announced its acquisition of The Crown & Anchor, Provincetown’s...

Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated CommLoan has streamlined the process of obtaining commercial real estate financing WARRINGTON, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company. CommLoan will retain key employees and become a subsidiary of Windtree. Windtree has provided bridge financing to CommLoan during this transition period. “Windtree is pleased to add a revenue generating fintech...

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued and outstanding shares, tendered prior to the expiration of the initial offering period The subsequent offering period has commenced and will expire at 12:01 a.m. Eastern Time on Thursday, December 18, 2025 MAINZ, Germany, December 3, 2025 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that 184,071,410 shares of CureVac N.V. (Nasdaq: CVAC, “CureVac”), representing approximately 81.74% of CureVac’s issued and outstanding shares, were validly tendered and not properly withdrawn prior to the expiration of the initial offering period at 9:00 a.m. Eastern Time on December 3, 2025. As a result, the minimum condition for the exchange offer (the “Offer”) has been satisfied, and all validly...

Eliminating Charging Anxiety: The combined entity will focus on commercializing StoreDot’s XFC batteries to solve the #1 consumer pain point in the electric vehicle space: long charging times. The combined entity intends to eliminate range and charging anxiety, leveraging StoreDot’s proven Extreme Fast Charging – XFC – technology.  Significant Market Opportunity: The combined entity targets the rapidly expanding EV battery market. StoreDot believes that it is positioned to capture significant market share by addressing the primary barrier to EV adoption: charging speed.  Scalable, Asset-Light Business Model: StoreDot employs a capital-efficient licensing model designed to be a “drop-in” solution compatible with existing Lithium-ion production lines. This accelerates the path to mass-market adoption...

Tongon-Mine-Côte d’IvoireTongon-Mine-Côte d’IvoireABU DHABI, United Arab Emirates, Dec. 03, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent industries, announces the completion of a US$150 million acquisition financing package to Atlantic Group to support the buyout of Tongon gold mine in Côte d’Ivoire from Barrick Mining Corporation (“Barrick Mining”). HighlightsAppian is providing US$150 million to support Atlantic Group’s buyout of Tongon mine from Barrick Mining Tongon is a gold-producing mine located in Côte d’Ivoire with significant upside potential The deal marks Appian’s fourth credit investment in the gold sector in 2025, further strengthening Appian’s exposure...

RESEARCH TRIANGLE PARK, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), with respect to BioCryst’s proposed acquisition of Astria Therapeutics, Inc. (the “Merger”). Termination of the waiting period under the HSR Act satisfied one of the conditions for consummation of the Merger. BioCryst expects the Merger to close in the first quarter of 2026, subject to other customary closing conditions. About BioCryst PharmaceuticalsBioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of...